British American Tobacco (ADR) (BTI)
Sells cigarettes alongside Vuse vapour, glo heated tobacco, and Velo oral nicotine.
Something off on this page? Send us feedback.
Sells combustible cigarettes and smokeless nicotine products across the United States and international markets, anchored by brands including Newport, Camel, Vuse, glo, and Velo. Combustibles remain the economic base while management shifts investment toward vapour, heated tobacco, and oral nicotine under product-specific regulation.
Produces and sells combustible cigarettes, vapour devices, heated tobacco, modern oral nicotine, and traditional oral products. International cigarette brands include Dunhill, Lucky Strike, Pall Mall, and Rothmans, while the Reynolds American business supplies Newport, Camel, and Natural American Spirit in the United States.
Vuse, glo, and Velo anchor the smokeless portfolio across vapour, heated tobacco, and oral nicotine. Combustibles still provide most revenue, while product development and investment are being directed toward a predominantly smokeless mix.
Operations span the United States, Americas and Europe, and Asia Pacific, Middle East and Africa. Cigarette litigation and settlement payments remain structural obligations, while each new Vuse variant depends on its own FDA marketing authorization in the United States.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 7, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $40 | Target: $68.10 |
| Jul 21, 2026 | BTIG | Initiate | Rating: — | |
| Sep 8, 2025 | Argus Research | Upgrade | ||
| Jan 27, 2025 | UBS | Upgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $3.38B · Total debt $46.83B · Total assets $144.76B · Shareholders' equity $64.61B
- Revenue
- $16.46B
- Operating income
- $6.29B
- Net income
- $4.29B
Reported in GBP, converted at the latest exchange rate
HistoryDividendAnnual yieldUpcoming
| Institutions | 15.23% | 328.47M ADS | |
|---|---|---|---|
| 947 holders · as of Jun 30, 2026 | |||
| Other | 84.77% | 1.83B ADS | |
| remainder | |||
2.16B ADS as of Aug 26, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Capital International InvestorsInstitution | 2.28% | 49.13M ADS | as of Jun 30, 2026 |
FMR LLCInstitution | 2.05% | 44.16M ADS | as of Jun 30, 2026 |
Capital Research Global InvestorsInstitution | 1.41% | 30.33M ADS | as of Jun 30, 2026 |
GQG Partners LLCInstitution | 1.14% | 24.57M ADS | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 0.93% | 20.16M ADS | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Philip Morris International
Global cigarettes, IQOS heated tobacco and ZYN nicotine pouches
- Altria Group
U.S. cigarettes leader with oral nicotine and constrained e-vapor exposure
- Turning Point Brands
U.S. oral-nicotine and smokeless-tobacco challenger
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| British American Tobacco (ADR) | $56.16 | +0.74% | $120.25B | 14.3 | — | 3.5 | −0.1% |
| Philip Morris International | $188.41 | +0.50% | $292.21B | 26.9 | 21.5 | 6.9 | +10.4% |
| Altria Group | $68.75 | +0.31% | $114.44B | 14.5 | 11.9 | 5.2 | +1.3% |
| Turning Point Brands | $60.16 | −1.88% | $1.19B | 26.3 | 55.3 | 2.3 | +22.6% |
| Median | 26.3 | 21.5 | 5.2 | +10.4% |